Status:
UNKNOWN
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
Lead Sponsor:
Peking Union Medical College Hospital
Collaborating Sponsors:
Peking University Cancer Hospital & Institute
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions:
Colorectal Cancer
Colorectal Cancer Liver Metastasis
Eligibility:
All Genders
18+ years
Brief Summary
The therapeutic regimens of adjuvant and neoadjuvant chemotherapy for colorectal cancer (CRC) remain largely relied on clinical experience, and thus preclinical models are needed to guide individualiz...
Eligibility Criteria
Inclusion
- More than 18 years old
- Diagnosed as colorectal cancer with or without liver metastases before
- Pathologically proven colorectal cancer after surgery
Exclusion
- Medical history with other malignancies or serious diseases
- Disable to sign the informed consent independently
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04755907
Start Date
March 1 2021
End Date
December 31 2023
Last Update
July 19 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China, 100021
2
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029
3
Beijing Cancer Hospital
Beijing, Beijing Municipality, China, 100143
4
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730